Related Experiment Video
Updated: Jul 15, 2026

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
Published on: June 3, 2018
Application of laser capture microdissection and differential display technique for screening of pathogenic genes
1Department of Gynecological Tumor, Affiliated Cancer Hospital, Tianjin Medical University, Tianjin, China. wenxin1973@163.com
Abstract:
The objective is to eliminate the interference from other cell types; gene fragments involved in endometrial carcinoma (EC) are screened and cloned. Human normal endometrial glandular epithelia and EC cells were harvested with laser capture microdissection (LCM). The purification and concentration of minimal RNA were used to screen differential expressed gene fragments involved in EC by fluoro differential display polymerase chain reaction (FDD-PCR). The differential gene fragments were cloned, sequenced, and then identified by reverse Northern blot hybridization. Positive fragments were analyzed with basic local alignment search tool (BLAST). Cyclin-dependent kinase 7 (CDK7) expressions in EC and normal endometrial tissue were tested by immunohistochemical staining. Of 38 differential bands, 3 bands were of high expression in normal endometrium and 35 in EC. Six positive differential gene fragments were obtained and BLAST analysis for them suggested that L1.1 was homologous (99% identical) to the CDK7; L1.9 had a 99% homology with protein phosphatase 1 regulatory (inhibitor) subunit 12 A (PPP1R12A); L1.21 and L1.22 showed a 100% homology with cellular repressor of E1A-stimulated genes 1 (CREG); and L1.25 and L1.26 indicated more than 98% homology with solute carrier family 39 (zinc transporter), member 10 (SLC39A10). Immunohistochemistry revealed that CDK7 expression was higher in EC than in normal endometrium. We conclude that pathogenic genes involved in EC are obtained with LCM and FDD-PCR. It has been first found that CDK7, PPP1R12A, CREG, and SLC39A10 are correlative with EC from gene level. CDK7 is strongly associated with EC and can be used as potential molecular marker of EC for further studies.
Insights
This study identified key genes, including Cyclin-dependent kinase 7 (CDK7), involved in endometrial carcinoma (EC). These findings highlight potential new molecular markers for EC detection and research.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Endometrial carcinoma (EC) presents diagnostic challenges due to cellular heterogeneity.
- Accurate identification of EC-specific molecular markers is crucial for improved diagnosis and treatment.
Observation:
- Laser capture microdissection (LCM) and fluoro differential display polymerase chain reaction (FDD-PCR) were employed to isolate and screen differentially expressed genes in EC.
- Six unique gene fragments were identified, showing high homology to known genes including Cyclin-dependent kinase 7 (CDK7), PPP1R12A, CREG, and SLC39A10.
Findings:
- Gene expression analysis revealed significant differences between EC and normal endometrial tissues.
- Cyclin-dependent kinase 7 (CDK7) expression was notably elevated in EC tissues compared to normal tissues.
- CDK7, PPP1R12A, CREG, and SLC39A10 were identified as potentially correlated with EC at the gene level.
Implications:
- The identified genes, particularly CDK7, show strong association with EC and may serve as novel molecular markers.
- This research provides a foundation for developing new diagnostic tools and therapeutic strategies for endometrial carcinoma.
- The study demonstrates the efficacy of LCM and FDD-PCR in discovering disease-specific genetic alterations.
More Related Videos
13:01Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
Published on: June 3, 2022
07:46Platform for Quantitative Detection of Endometrial Immune Cells Based on Immunohistochemistry and Digital Image Analysis
Published on: October 13, 2023